Some studies (McWhirter et al., 2006; Kretz-Rommel et al., 2007; Rygiel et al., 2012) show that CD200-CD200R interaction inhibits anti-tumor immune responses and CD200-CD200R signaling pathway plays a pro-tumor role. The gene discussed is CD200; the disease is neoplasm.